Raquel Resendes

@FourtoldTweets Thank you for the warm welcome. I'm very excited to be part of this fabulous team!

📢 Introducing Raquel Resendes, the newest addition to the Fourtold family. With an impressive background in EU public affairs and advocacy, she bolsters our existing expertise in healthcare policy and comms. We're thrilled to have Raquel on board! 💪 linkedin.com/pulse/fourtold…

+++ News +++ @CureVacRNA and #Bayer join forces on #COVID19 vaccine candidate CVnCoV. Learn more: media.bayer.com/baynews/baynew…

Exciting medical science – now law-makers around the world can follow and make precision oncology a priority.

The answer to achieve healthcare savings is in the use of technology says @ViolaRoberto #EUHealthSummit

#NEWS @US_FDA approves first-in-class drug specifically designed to treat adults and children with #TRKfusioncancer. This marks an important milestone for this #patient group who previously had limited treatment options. #precisionmedicine #advancingcare bit.ly/News_Bayer

Investing in IT infrastructures is key to create EU ecosystem 4 sharing data says Dr Auer @EU2018AT #Bigdatahealth

Wouldn’t it be wonderful if we are able to predict a heart attack prior to symptoms? Joachim Luithle #bigdatahealth @bayerpharma

Patient Electronic Health Records could be used to supplement clinical trial data says Joachim Luithle #bigdatahealth @bayerpharma

Big Data for Better Health #bigdatahealth

“Digitization in health care can help get the right treatment to the right patient at the right time.” @BayerPharma @Bayer

This evening we will be discussing the value of #bigdata in #healthcare and what can be done to unleash it — while respecting privacy and security concerns. politi.co/2CnjRWa | #BigDataHealth pres. by @Bayer | moderated by @katiedjennings

Innovation in cardiovascular diseases @EFPIA @BayerPharma @Europarl_EN

Curious to find out more about the science behind the medicines? Come join us on the 3rd floor of the ASP building the @Europarl_EN for @EFPIA ´s Unlocking tomorrow’s cures exhibition #WeWontRest

Inspiring work being presented today @EFPIA @BayerPharma @Europarl_EN

On 23 May (10:00-11:00), join @BayerPharma Chitkala Kalidas as she discusses histology-independent development and highlights some examples of therapies under development for patients with rare cancers #HealthInnovationEU #WeWontRest bit.ly/2I3ZpYX

Join @EFPIA at the European Parliament this week for a journey into the revolution of healthcare #WeWontRest #unlockingtomorrowscures #escaperoom efpia.eu/news-events/ev… …

Come join us in the @Europarl_EN as of 22 May to learn more about the cutting-edge science behind new treatments twitter.com/EFPIA/status/9…

Read how the life-sciences industry takes action to tackle AMR through the AMR Industry Alliance @EFPIA twitter.com/IFPMA/status/9…